Section Arrow
EVGN.NASDAQ
- Evogene Ltd.
Quotes are at least 15-min delayed:2025/03/13 18:15 EDT
Last
 1.38
-0.02 (-1.43%)
Day High 
1.4419 
Prev. Close
1.4 
1-M High
1.55 
Volume 
27.94K 
Bid
1.36
Ask
1.47
Day Low
1.365 
Open
1.38 
1-M Low
1.3 
Market Cap 
9.12M 
Currency USD 
P/E 0.3 
%Yield -- 
10-SMA 1.42 
20-SMA 1.43 
50-SMA 1.56 
52-W High 8.996 
52-W Low 1.2 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-4.46/-1.00
Enterprise Value
19.77M
Balance Sheet
Book Value Per Share
-0.22
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
5.64M
Operating Revenue Per Share
0.37
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ADTXAditxt Inc0.0334-0.0234-41.20%0PE
CRVOCervoMed5.79-0.38-6.16%4.66PE
HEPAHepion Pharmaceuticals0.0378-0.011-22.54%-- 
IPAImmunoPrecise Antibodies Ltd0.405+0.0417+11.48%-- 
ONCOOnconetix Inc0.1298-0.0412-24.09%-- 
Quotes are at least 15-min delayed:2025/03/13 18:15 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules and genetic elements as the core components for such products. Itholds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment followed by Industry.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.